Second-generation DNA-templated macrocycle libraries for the discovery of bioactive small molecules
- PMID: 29610462
- PMCID: PMC6014893
- DOI: 10.1038/s41557-018-0033-8
Second-generation DNA-templated macrocycle libraries for the discovery of bioactive small molecules
Erratum in
-
Author Correction: Second-generation DNA-templated macrocycle libraries for the discovery of bioactive small molecules.Nat Chem. 2019 Nov;11(11):1067. doi: 10.1038/s41557-019-0360-4. Nat Chem. 2019. PMID: 31576016
Abstract
DNA-encoded libraries have emerged as a widely used resource for the discovery of bioactive small molecules, and offer substantial advantages compared with conventional small-molecule libraries. Here, we have developed and streamlined multiple fundamental aspects of DNA-encoded and DNA-templated library synthesis methodology, including computational identification and experimental validation of a 20 × 20 × 20 × 80 set of orthogonal codons, chemical and computational tools for enhancing the structural diversity and drug-likeness of library members, a highly efficient polymerase-mediated template library assembly strategy, and library isolation and purification methods. We have integrated these improved methods to produce a second-generation DNA-templated library of 256,000 small-molecule macrocycles with improved drug-like physical properties. In vitro selection of this library for insulin-degrading enzyme affinity resulted in novel insulin-degrading enzyme inhibitors, including one of unusual potency and novel macrocycle stereochemistry (IC50 = 40 nM). Collectively, these developments enable DNA-templated small-molecule libraries to serve as more powerful, accessible, streamlined and cost-effective tools for bioactive small-molecule discovery.
Conflict of interest statement
The authors declare the following competing financial interest(s): the authors are inventors on patents and patent applications describing DNA-templated synthesis methods and applications.
Figures
References
-
- Hüser J, Mannhold R, Kubinyi H, Folkers G. High-throughput screening in drug discovery. Wiley; 2006.
-
- Macarron R, et al. Impact of high-throughput screening in biomedical research. Nat Rev Drug Discovery. 2011;10:188–195. - PubMed
-
- Dandapani S, Marcaurelle LA. Grand Challenge commentary: accessing new chemical space for ‘undruggable’ targets. Nat Chem Biol. 2010;6:861–863. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
